Fundamental Data for BIOS

BIOSCRIP I(NSDQ:BIOS)

BioScrip provides comprehensive pharmaceutical care solutions. We partner with healthcare payors, pharmaceutical manufacturers, government agencies, physicians, and patients to deliver cost effective programs that enhance the quality of patient life. We focus our products and services in two core areas: specialty medication distribution and clinical management services, both nationally and community-based and pharmacy benefit management services.

# Employees: 1158

Address: 100 Clearbrook Road,Elmsford,NY,USA

Phone: 914 460-1600

Fax: 952 979-3713

Website: www.bioscrip.com

Email: investor@bioscrip.com

Sector: Retail/Wholesale

Industry: RETAIL-DRUG STR

Executive Officers

Richard H. Friedman (Chmn.; C.E.O.)

Michael Kooper (Dir.)

Stanley G. Rosenbaum (C.F.O.)

Louis T. DiFazio Ph.D. (Dir.)

David R. Hubers (Dir.,)

Dividend

Ex-Dividend Date: N/A

Annual Dividend: N/A

Current Dividend Yield: N/A

Dividend Paid (3 months): N/A

Indicated Dividend: N/A

Earnings

Last Earnings Date: 9/30/2009

Next Earnings Date(Expected): 3/9/2010

Mean EPS (Next Qtr): $0.12

Mean EPS (Year): $0.46

Mean Estimate(Long Term): $20.00

P/E Ratio(Based on EPS estimate): 16.730

Number of Estimates: 3

Shares Performance

Period	BIOS	Compare to S&P
YTD	244.14 %	184.82 %
4 Weeks	-1.04 %	-2.10 %
12 Weeks	30.38 %	22.92 %

Shares Information

Analyst Coverage: Y

Avg Volume: 505092

Shares Outstanding: 38M

Market Cap: $0.30B

52 Week High: $8.90

52 Week Low: $1.36

P/E Ratio: 18.190

PEG Ratio: 0.840

Split: On 1/1/1990 BIOS split by factor of 2.000

Earnings Performance

EPS Growth in Last Quarter: 27.27 %

EPS Growth in Last Year: 133.33 %

Sales Growth in Last Quarter: 1.44 %

Sales Growth in Last Quarter: -7.22 %

Financials

Qtr Book Value: $2.63

Cash Flow/Share: $2.76

Change in Payout Ratio: 0.000

Price/Sales: 0.220